1. Pink Sheet
  2. >>Compliance

Human-Machine Interface Ratted On Apollo Workers Who Fibbed Batch Data

 
• By Bowman Cox

The US FDA applied laboratory data integrity inspection technique to production floor, leading to warning letter, import alert.

Vintage inscription made by old typewriter, warning
Apollo's human-machine interface did not lie.

A warning letter the US Food and Drug Administration posted 7 January provides yet another indication that the agency is taking a powerful method for checking on laboratory data integrity and adapting it for use in the production environment.

Data integrity failures related to production equipment identified during a 12-16 August inspection led the agency on 16 December to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

EU Critical Medicines Act May Include Investigational Products & Mandatory Redistribution Measure

 
• By Neena Brizmohun

The inclusion of investigational drugs in the Critical Medicines Act and new provisions on stockpiling are among the raft of amendments the European Parliament has made to the draft legislation.

Drug Quality Assurance Inspections Closer To Pre-Pandemic Levels, But Still Behind

 
• By Grace Moser

The CDER FY 2024 annual inspections report says the largest inspection increase was in China.

Taiwan To Phase Out Paper Drug Package Inserts By 2027

 
• By Eliza Slawther

Companies that market drugs in Taiwan must submit electronic versions of their package inserts to Taiwan’s drug regulator by the year-end, lawyers say.

Maze Therapeutics’ Claims For Unapproved Kidney Disease Drug Face Regulatory Scrutiny

 
• By Sue Sutter

Vertex challenged Maze’s claims suggesting better potency and efficacy relative to Vertex’s investigational product, but Maze declined to participate in the National Advertising Division’s self-regulatory process.

More from Pink Sheet

EU Critical Medicines Act May Include Investigational Products & Mandatory Redistribution Measure

 
• By Neena Brizmohun

The inclusion of investigational drugs in the Critical Medicines Act and new provisions on stockpiling are among the raft of amendments the European Parliament has made to the draft legislation.

EU HTA Regulation: Key Gaps Identified In Support For Small Companies And Experts

 
• By Eliza Slawther

A meeting between the European Commission and industry stakeholders has revealed several areas of importance and lessons learned in relation to the EU Health Technology Assessment Regulation, which began to apply to certain medicinal products this year.

89 Complete Response Letters For Unapproved Drugs, One Huge Leap For US FDA Transparency

 
• By Bridget Silverman

The US FDA’s unprecedented publication of 89 recent CRLs for unapproved products comes with a promise to release future letters more promptly.